tVNS

Neuronium
06/16/2024
last update18 June 2024

tVNS Shows Promising Results in Ulcerative Colitis

Based on the provided search results, here are the key points regarding the use of transcutaneous vagus nerve stimulation (tVNS) for ulcerative colitis:

[1] The EVASION-UC study is a prospective clinical trial investigating whether tVNS is effective at reducing stress-induced inflammatory cytokine levels in patients with quiescent ulcerative colitis.

[2] A new study published in Bioelectronic Medicine investigated tVNS as a potential treatment for ulcerative colitis. The small proof-of-concept trial enrolled 22 volunteers aged 10-21 with mild-to-moderate ulcerative colitis.

– The trial found that tVNS, applied through the ear, reduced symptoms and levels of fecal calprotectin (a biomarker of intestinal inflammation) in these patients.

[5] This commentary discusses the promising results of a pilot randomized study on non-invasive tVNS (taVNS) in pediatric inflammatory bowel disease patients, including those with ulcerative colitis.

– The study found that taVNS reduced fecal calprotectin levels and improved symptoms in children and young adults with mild-to-moderate ulcerative colitis.

Potential Mechanisms and Future Directions

[4] Several studies have investigated the potential mechanisms by which tVNS could benefit inflammatory bowel diseases like ulcerative colitis, including:

– Modulation of the inflammatory response
– Reduction of pro-inflammatory cytokine levels
– Improvement in vagal tone and autonomic function

[5] The commentary notes that larger randomized, double-blinded controlled studies with long-term follow-up are needed to confirm these promising results of non-invasive tVNS in managing ulcerative colitis and other inflammatory bowel diseases.